Search

Gerresheimer AG

Avatud

SektorTervishoid

68.15 -2.29

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

66.1

Max

70.05

Põhinäitajad

By Trading Economics

Sissetulek

11M

38M

Müük

70M

569M

P/E

Sektori keskmine

22.028

63.778

Aktsiakasum

1.63

Dividenditootlus

1.71

Kasumimarginaal

6.731

Töötajad

12,142

EBITDA

16M

117M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+46.65% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

1.71%

2.39%

Järgmine tulemuste avaldamine

11. apr 2025

Turustatistika

By TradingEconomics

Turukapital

-382M

2.4B

Eelmine avamishind

70.44

Eelmine sulgemishind

68.15

Uudiste sentiment

By Acuity

33%

67%

96 / 386 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

Gerresheimer AG Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

13. mai 2024, 11:16 UTC

Peamised uudised

German Companies Bet on AI But Payoff Could Be Years Away -- Talking Markets

Gerresheimer AG Prognoos

Hinnasiht

By TipRanks

46.65% tõus

12 kuu keskmine prognoos

Keskmine 102.73 EUR  46.65%

Kõrge 122.5 EUR

Madal 93 EUR

Põhineb 13 Wall Streeti analüütiku instrumendi Gerresheimer AG 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

13 ratings

12

Osta

1

Hoia

0

Müü

Tehniline skoor

By Trading Central

N/A / 74.9Toetus ja vastupanu

Lühikene perspektiiv

Weak Bullish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Weak Bearish Evidence

Sentiment

By Acuity

96 / 386 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.